Home › Therapeutic areas › Cardiovascular › Heart Failure
Heart Failure (3 companies)
Companies with an active program in Heart Failure.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CRDL | Cardiol Therapeutics | Cardiovascular Rare | 2 | Phase 3 | $121M | 4 |
| EWTX | Edgewise Therapeutics | Cardiovascular | 1 | Phase 2 | $4.93B | 3 |
| MESO | Mesoblast | CardiovascularGI/Hepatology+2 Rare | 1 | Approved | $1.85B | 5 |
No companies match.